|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 401/06 | (2006.01) |
| A61K 31/506 | (2006.01) | ||
| A61K 31/53 | (2006.01) | ||
| A61K 31/5377 | (2006.01) | ||
| A61K 31/5383 | (2006.01) | ||
| A61K 31/55 | (2006.01) | ||
| A61P 31/14 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| C07D 251/46 | (2006.01) | ||
| C07D 401/04 | (2006.01) | ||
| C07D 401/14 | (2006.01) | ||
| C07D 403/06 | (2006.01) | ||
| C07D 403/14 | (2006.01) | ||
| C07D 405/14 | (2006.01) | ||
| C07D 409/14 | (2006.01) | ||
| C07D 413/14 | (2006.01) | ||
| C07D 417/06 | (2006.01) | ||
| C07D 417/14 | (2006.01) | ||
| C07D 471/04 | (2006.01) |
| (11) | Number of the document | 4122926 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22733282.2 |
| Date of filing the European patent application | 2022-02-17 | |
| (97) | Date of publication of the European application | 2023-01-25 |
| (45) | Date of publication and mention of the grant of the patent | 2025-06-04 |
| (46) | Date of publication of the claims translation | 2025-07-25 |
| (86) | Number | PCT/JP2022/006495 |
| Date | 2022-02-17 |
| (87) | Number | WO 2022/138987 |
| Date | 2022-06-30 |
| (30) | Number | Date | Country code |
| 2021068672 | 2021-04-14 | JP | |
| 2021105802 | 2021-06-25 | JP | |
| 2021153819 | 2021-09-22 | JP |
| (72) |
TACHIBANA, Yuki , JP
UEHARA, Shota , JP
UNOH, Yuto , JP
NAKAHARA, Kenji , JP
TAODA, Yoshiyuki , JP
KASAMATSU, Koji , JP
YAMATSU, Yukiko , JP
ANDO, Shigeru , JP
IIMURO, Atsuhiro , JP
SUTO, Takahiro , JP
SASAKI, Michihito , JP
|
| (73) |
Shionogi & Co., Ltd. ,
1-8, Doshomachi 3-chome
Chuo-ku, Osaka-shi, Osaka 541-0045,
JP
National University Corporation Hokkaido University , Kita 8-jyo Nishi 5-chome Kita-ku, Sapporo-shi, Hokkaido 060-0808, JP |
| (74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
| (54) | Triazino dariniai, turintys virusų replikaciją slopinantį poveikį, ir juos apimanti farmacinė kompozicija |
| TRIAZINE DERIVATIVES HAVING VIRUS REPLICATION INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME |